Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 1.00 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 1.00 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CCR1 | P32246 | 2/20 | 0.48 |
| ▸ | CCR5 | P51681 | 2/20 | 0.48 |
| ▸ | CCR8 | P51685 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21174 | 1.00 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| SCHEMBL27972393 | 1.00 | EHMT2 (1.00) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Hydrochloric Acid SCHEMBL8671988 | 0.97 | EHMT2 (0.94) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Hydrochloric Acid SCHEMBL11726971 | 0.97 | EHMT2 (0.94) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Hydrogen Sulfide SCHEMBL3347200 | 0.97 | EHMT2 (0.94) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Ammonia Solution, Strong SCHEMBL421495 | 0.97 | EHMT2 (0.94) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Hydrochloric Acid SCHEMBL10707236 | 0.97 | EHMT2 (0.94) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Ethylene SCHEMBL19138148 | 0.95 | EHMT2 (0.90) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| Methyl Alcohol SCHEMBL28484914 | 0.95 | EHMT2 (0.90) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E | |
| SCHEMBL11825400 | 0.90 | EHMT2 (0.81) | EHMT2EHMT1APOBEC3GL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4677111-A2 | SYSTEMS, METHODS, AND COMPOSITIONS FOR SEQUENCING | Ultima Genomics, Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4658772-A1 | IN VITRO TRANSCRIPTION METHODS AND COMPOUNDS FOR USE THEREIN | Genscript USA Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| CN-120130495-A | Famoxadone-containing material agricultural bactericidal composition of (2) | 安徽广信农化股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119552316-A | Double-response amphiphilic polymer and preparation method and application thereof | 华东理工大学 | 2025-03-04 | — | — | CN | claimed |
| CN-116041286-B | Preparation method of 3, 3-difluoro-4-hydroxy-5- (hydroxymethyl) dihydrofuran-2 (3H) -ketone | 苏州永健生物医药有限公司 | 2025-01-28 | — | — | CN | claimed |
| US-20240391873-A1 | PROCESS FOR THE PREPARATION OF PEGYLATED ADRENOMEDULLIN, ITS INTERMEDIATES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2024-11-28 | — | — | US | claimed |
| WO-2024186844-A2 | SYSTEMS, METHODS, AND COMPOSITIONS FOR SEQUENCING | ULTIMA GENOMICS, INC. (US) | 2024-09-12 | — | — | WO | claimed |
| WO-2024163689-A1 | IN VITRO TRANSCRIPTION METHODS AND COMPOUNDS FOR USE THEREIN | GENSCRIPT USA INC. (US) | 2024-08-08 | — | — | WO | claimed |
| EP-4387673-A1 | PROCESS FOR THE PREPARATION OF PEGYLATED ADRENOMEDULLIN, ITS INTERMEDIATES AND USE THEREOF | Bayer Aktiengesellschaft (DE) | 2024-06-26 | — | — | EP | claimed |
| US-20240132955-A1 | BENIGN SCAR-FORMING CLEAVABLE LINKERS | ULTIMA GENOMICS, INC. | 2024-04-25 | — | — | US | claimed |
| CN-114805527-A | RAS inhibitory peptides and uses thereof | 哈佛大学的校长及成员们 | 2022-07-29 | — | — | CN | claimed |
| CN-113463074-B | Copper deposition composition and copper deposition method | 广东硕成科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114306282-A | Diagnosis and treatment integrated drug-loaded nanoparticle for enhancing iron death effect and preparation method and application thereof | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 2022-04-12 | — | — | CN | claimed |
| CN-114315689-A | Disulfanylphthalimide compound, preparation method and application thereof | 四川大学 | 2022-04-12 | — | — | CN | claimed |
| CN-114249688-A | Synthetic method of 2,2' -dipyridyl disulfide | 烟台中科荣达新材料有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114163987-A | Photosensitive response hydrogel and application thereof in preparation of photochromic soft material | 洛阳师范学院 | 2022-03-11 | — | — | CN | claimed |
| CN-114133455-A | Synthesis method of desmopressin acetate dimer impurity | 深圳翰宇药业股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114099706-A | MOF drug carrier for treating breast cancer and preparation method thereof | 江南大学 | 2022-03-01 | — | — | CN | claimed |
| CN-108926718-B | Amphiphilic polymer prodrug capable of releasing original drug in reduction response manner and preparation method and application thereof | 烟台药物研究所 | 2022-02-11 | — | — | CN | claimed |
| CN-114028583-A | Degradable silicon-based carrier material based on ZnO composite mesoporous silica and preparation method and application thereof | 四川大学 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391873-A1 | PROCESS FOR THE PREPARATION OF PEGYLATED ADRENOMEDULLIN, ITS INTERMEDIATES AND USE THEREOF | ADM2, HAMP, SERPINC1 | EHMT2 4698/4885EHMT1 4482/4885APOBEC3G 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.